Preservative Free Eye drops solution in single-dose container for the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.


The first and only preservative-free latanoprost, Monopost removes the risk of ocular surface problems that have been reported to be caused by long-term preservative containing eye drops.

Monopost has been shown to provide non-inferior IntraOcular Pressure (IOP) control compared to Xalatan with statistically significantly lower hyperaemia and symptoms on instillation.1

Studies where patients have been switched from preserved to preservative-free latanoprost (Monopost) have demonstrated reductions in the frequency and severity of hyperaemia and other symptoms.2

Rouland, J.F. et al. Br J Ophthalmol. 2013;97(2):196-200
Misiuk-Hojło, M. et al. EVER 2014 congress. Poster #T018

Related Files

Adverse events should be reported. Reporting forms are available and information can be found at Adverse events should be reported to Thea Pharmaceuticals Ltd

Contact Us

Is there anything we can help you with? From requesting a product sample, arranging a visit from one of our helpful customer representatives, or simply asking us a question about Thea Pharmaceuticals products. Use the form and we'll be in touch as soon as possible.

Fields indicated with * are required

Form Icon